REGULATED PRESS RELEASE published on 02/27/2024 at 17:50, 2 years 6 months ago ALTAREIT : BUSINESS REVIEW ANNUAL RESULTS 2023
REGULATED PRESS RELEASE published on 02/27/2024 at 17:46, 2 years 6 months ago ALTAREIT : RAPPORT D’ACTIVITE 31 DÉCEMBRE 2023
REGULATED PRESS RELEASE published on 02/27/2024 at 17:45, 2 years 6 months ago ALTAREA : CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023
REGULATED PRESS RELEASE published on 02/27/2024 at 17:45, 2 years 6 months ago ALTAREA : COMPTES CONSOLIDES DE L’EXERCICE CLOS LE 31 DECEMBRE 2023
REGULATED PRESS RELEASE published on 02/27/2024 at 17:45, 2 years 6 months ago ALTAREA : ANNUAL RESULTS AND BUSINESS REVIEW 2023
REGULATED PRESS RELEASE published on 02/27/2024 at 17:45, 2 years 6 months ago ALTAREA : COMMUNIQUE DE PRESSE ET RAPPORT D'ACTIVITE (RESULTATS ANNUELS 2023)
REGULATED PRESS RELEASE published on 02/27/2024 at 17:45, 2 years 6 months ago ALTAREIT : COMPTES CONSOLIDES DE L’EXERCICE CLOS AU 31 DECEMBRE 2023
PRESS RELEASE published on 02/27/2024 at 17:41, 2 years 6 months ago BILENDI: Chiffre d’affaires annuel 2023 : 62,7 M€, Croissance organique à taux de change constant : +4,5% au T4, +2,7% sur l’année Bilendi annonce un chiffre d'affaires annuel de 62,7 M€ pour 2023 avec une croissance organique de +4,5% au T4 et de +2,7% sur l'année. Objectif de 100 M€ de CA d'ici 2026. Prochaine publication : résultats annuels 2023 le 3 avril 2024 Chiffre D'affaires Résultats Annuels Croissance Organique Bilendi Objectif 2026
PRESS RELEASE published on 02/27/2024 at 17:41, 2 years 6 months ago BILENDI: 2023 annual revenues: 62,7 M€, Organic growth at constant exchange rates: +4.5% in Q4, +2.7% over the full year Bilendi reports 2023 annual revenues of 62.7 M€, with +4.5% organic growth in Q4 and +2.7% over the full year. The company aims for 100 M€ sales by 2026 Growth Strategy Financial Performance Organic Growth 2023 Annual Revenues Bilendi
PRESS RELEASE published on 02/27/2024 at 17:40, 2 years 6 months ago Breakthrough: Patients and Ocularists Impressed by Quality of Computer-Generated 3D-Printed Eye Prostheses Fraunhofer IGD's 3D printing technology provides high-quality ocular prostheses at Moorfields Eye Hospital. Research published in Nature Communications showcases life-changing results for over 200 patients Fraunhofer IGD Ocular Prostheses 3D Printing Technology Moorfields Eye Hospital Cuttlefish:Eye Software
Published on 09/24/2026 at 14:55, 3 hours 43 minutes ago Nextech3D.ai Surpasses $1 Million in New Customer Contract Value, Expands AI Software Portfolio with KATE and Grows Multi-Year Enterprise Agreements
Published on 09/24/2026 at 14:30, 4 hours 8 minutes ago Solitario Resources CEO to Present at the 38th Annual Mining Forum Americas 2026 Conference
Published on 09/24/2026 at 14:00, 4 hours 38 minutes ago Horizon Aircraft to Report First Quarter 2027 Results and Provide a Business Update on October 9, 2026
Published on 09/24/2026 at 14:00, 4 hours 38 minutes ago Reeflex Completes $1.23 Million Goes Order on Schedule Ahead of Vancouver Investor Conference
Published on 09/24/2026 at 18:15, 22 minutes ago Epanko Value Engineering Identifies 20% Production Increase
Published on 09/24/2026 at 18:05, 32 minutes ago DCK Tools Showcases Expanded Outdoor Power Equipment Lineup at Salonvert 2026
Published on 09/24/2026 at 18:05, 32 minutes ago EUHOMY CLOSES IFA 2026 WITH NINE HONORS ACROSS ITS ICE MAKER LINEUP
Published on 09/24/2026 at 18:00, 37 minutes ago ALTHEORA : Résultats semestriels 2026 - Cap sur la rentabilité et le désendettement
Published on 09/24/2026 at 18:31, 6 minutes ago LNA SANTE : Mise à disposition du rapport financier semestriel 2026
Published on 09/24/2026 at 18:00, 38 minutes ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2026
Published on 09/24/2026 at 18:00, 38 minutes ago GUILLEMOT CORPORATION : Mise à disposition du rapport financier semestriel au 30 juin 2026